Ivantis, Inc.

This study tested a small device called the Hydrus Microstent in 217 adults with open-angle glaucoma that was not well controlled with other treatments. The goal was to see if the implant could safely lower eye pressure and reduce the need for eye drops. After 12 months, many pat…